Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1992 Apr;40(4):371-9.

[A newly discovered chemotactic factor for neutrophil: interleukin 8]

[Article in Japanese]
Affiliations
  • PMID: 1593764
Review

[A newly discovered chemotactic factor for neutrophil: interleukin 8]

[Article in Japanese]
N Mukaida. Rinsho Byori. 1992 Apr.

Abstract

A potent peptide chemotactic factor for leukocytes has been purified from lipopolysaccharide (LPS)-stimulated human peripheral blood mononuclear cell culture supernatant, followed by its cDNA cloning and its expression in Escherichia coli. This factor was named interleukin-8 (IL-8) since it is produced by various kinds of cells in response to inflammatory stimuli including LPS, IL-1 and tumor necrosis factor (TNF) and has pleiotropic effects on T lymphocytes and basophils as well as neutrophils. The receptors for IL-8 contain seven transmembrane domains as revealed by cDNA cloning, suggesting that they are a member of superfamily of G-protein-coupled receptors. The transcription of IL-8 gene is presumed to be regulated by the action of two kinds of transcription factors, NF-kappa B and NF-IL6, both of which are supposed to be involved in the activation of acute phase reactant genes, suggesting that the activation of IL-8 gene is a good model for elucidating the molecular mechanism of the transcription of these genes. In various kinds of diseases in which neutrophilia or neutrophil infiltration is found, the increase of IL-8 level in body fluids is often observed. The clarification of the role of IL-8 in the process of these inflammatory diseases will lead to the development of a novel kind of anti-inflammatory or immunomodulating agents.

PubMed Disclaimer

Similar articles

LinkOut - more resources

  NODES
twitter 2